Industry: Chemical & Material
Published Date: 2025-03-01
Pages: 91 Pages
Report ld: 4351590
Request Sample
Customized Report
Etonogestrel Market Size(US$)

CAGR 2025-2031
3.9%
Market Size,2031
USD 1,212
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Etonogestrel was estimated to be worth US$ 933 million in 2024 and is forecast to a readjusted size of US$ 1212 million by 2031 with a CAGR of 3.9% during the forecast period 2025-2031.
Etonogestrel is a synthetic progestin (a type of synthetic progesterone) used in various hormonal contraceptives and treatments for certain gynecological conditions. It is primarily known for its role in birth control methods, where it is often combined with ethinyl estradiol or used alone in progestin-only contraceptives.
North American market for Etonogestrel was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Etonogestrel was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Etonogestrel was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Etonogestrel include Organon, Aspen API, Gedeon Richter, ToSun Pharm, WUHAN XINXINJIALI BIOTECHNOLOGY, Widely Chemical, Shanghai Yuanye Bio-Technology, Hubei Rishengchang, Wuhan NewGreat Chemical, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Etonogestrel, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Etonogestrel by region & country, by Type, and by Application.
The Etonogestrel market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Etonogestrel.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Etonogestrel manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Etonogestrel in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Etonogestrel in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Etonogestrel Product Introduction
1.2 Global Etonogestrel Market Size Forecast
1.2.1 Global Etonogestrel Sales Value (2020-2031)
1.2.2 Global Etonogestrel Sales Volume (2020-2031)
1.2.3 Global Etonogestrel Sales Price (2020-2031)
1.3 Etonogestrel Market Trends & Drivers
1.3.1 Etonogestrel Industry Trends
1.3.2 Etonogestrel Market Drivers & Opportunity
1.3.3 Etonogestrel Market Challenges
1.3.4 Etonogestrel Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Etonogestrel Players Revenue Ranking (2024)
2.2 Global Etonogestrel Revenue by Company (2020-2025)
2.3 Global Etonogestrel Players Sales Volume Ranking (2024)
2.4 Global Etonogestrel Sales Volume by Company Players (2020-2025)
2.5 Global Etonogestrel Average Price by Company (2020-2025)
2.6 Key Manufacturers Etonogestrel Manufacturing Base and Headquarters
2.7 Key Manufacturers Etonogestrel Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Etonogestrel
2.9 Etonogestrel Market Competitive Analysis
2.9.1 Etonogestrel Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Etonogestrel Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Etonogestrel as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 More than 99%
3.1.2 Less than 99%
3.2 Global Etonogestrel Sales Value by Type
3.2.1 Global Etonogestrel Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Etonogestrel Sales Value, by Type (2020-2031)
3.2.3 Global Etonogestrel Sales Value, by Type (%) (2020-2031)
3.3 Global Etonogestrel Sales Volume by Type
3.3.1 Global Etonogestrel Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Etonogestrel Sales Volume, by Type (2020-2031)
3.3.3 Global Etonogestrel Sales Volume, by Type (%) (2020-2031)
3.4 Global Etonogestrel Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceuticals
4.1.2 Research
4.2 Global Etonogestrel Sales Value by Application
4.2.1 Global Etonogestrel Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Etonogestrel Sales Value, by Application (2020-2031)
4.2.3 Global Etonogestrel Sales Value, by Application (%) (2020-2031)
4.3 Global Etonogestrel Sales Volume by Application
4.3.1 Global Etonogestrel Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Etonogestrel Sales Volume, by Application (2020-2031)
4.3.3 Global Etonogestrel Sales Volume, by Application (%) (2020-2031)
4.4 Global Etonogestrel Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Etonogestrel Sales Value by Region
5.1.1 Global Etonogestrel Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Etonogestrel Sales Value by Region (2020-2025)
5.1.3 Global Etonogestrel Sales Value by Region (2026-2031)
5.1.4 Global Etonogestrel Sales Value by Region (%), (2020-2031)
5.2 Global Etonogestrel Sales Volume by Region
5.2.1 Global Etonogestrel Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Etonogestrel Sales Volume by Region (2020-2025)
5.2.3 Global Etonogestrel Sales Volume by Region (2026-2031)
5.2.4 Global Etonogestrel Sales Volume by Region (%), (2020-2031)
5.3 Global Etonogestrel Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Etonogestrel Sales Value, 2020-2031
5.4.2 North America Etonogestrel Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Etonogestrel Sales Value, 2020-2031
5.5.2 Europe Etonogestrel Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Etonogestrel Sales Value, 2020-2031
5.6.2 Asia Pacific Etonogestrel Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Etonogestrel Sales Value, 2020-2031
5.7.2 South America Etonogestrel Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Etonogestrel Sales Value, 2020-2031
5.8.2 Middle East & Africa Etonogestrel Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Etonogestrel Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Etonogestrel Sales Value and Sales Volume
6.2.1 Key Countries/Regions Etonogestrel Sales Value, 2020-2031
6.2.2 Key Countries/Regions Etonogestrel Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Etonogestrel Sales Value, 2020-2031
6.3.2 United States Etonogestrel Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Etonogestrel Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Etonogestrel Sales Value, 2020-2031
6.4.2 Europe Etonogestrel Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Etonogestrel Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Etonogestrel Sales Value, 2020-2031
6.5.2 China Etonogestrel Sales Value by Type (%), 2024 VS 2031
6.5.3 China Etonogestrel Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Etonogestrel Sales Value, 2020-2031
6.6.2 Japan Etonogestrel Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Etonogestrel Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Etonogestrel Sales Value, 2020-2031
6.7.2 South Korea Etonogestrel Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Etonogestrel Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Etonogestrel Sales Value, 2020-2031
6.8.2 Southeast Asia Etonogestrel Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Etonogestrel Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Etonogestrel Sales Value, 2020-2031
6.9.2 India Etonogestrel Sales Value by Type (%), 2024 VS 2031
6.9.3 India Etonogestrel Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Organon
7.1.1 Organon Company Information
7.1.2 Organon Introduction and Business Overview
7.1.3 Organon Etonogestrel Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Organon Etonogestrel Product Offerings
7.1.5 Organon Recent Development
7.2 Aspen API
7.2.1 Aspen API Company Information
7.2.2 Aspen API Introduction and Business Overview
7.2.3 Aspen API Etonogestrel Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Aspen API Etonogestrel Product Offerings
7.2.5 Aspen API Recent Development
7.3 Gedeon Richter
7.3.1 Gedeon Richter Company Information
7.3.2 Gedeon Richter Introduction and Business Overview
7.3.3 Gedeon Richter Etonogestrel Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Gedeon Richter Etonogestrel Product Offerings
7.3.5 Gedeon Richter Recent Development
7.4 ToSun Pharm
7.4.1 ToSun Pharm Company Information
7.4.2 ToSun Pharm Introduction and Business Overview
7.4.3 ToSun Pharm Etonogestrel Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 ToSun Pharm Etonogestrel Product Offerings
7.4.5 ToSun Pharm Recent Development
7.5 WUHAN XINXINJIALI BIOTECHNOLOGY
7.5.1 WUHAN XINXINJIALI BIOTECHNOLOGY Company Information
7.5.2 WUHAN XINXINJIALI BIOTECHNOLOGY Introduction and Business Overview
7.5.3 WUHAN XINXINJIALI BIOTECHNOLOGY Etonogestrel Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 WUHAN XINXINJIALI BIOTECHNOLOGY Etonogestrel Product Offerings
7.5.5 WUHAN XINXINJIALI BIOTECHNOLOGY Recent Development
7.6 Widely Chemical
7.6.1 Widely Chemical Company Information
7.6.2 Widely Chemical Introduction and Business Overview
7.6.3 Widely Chemical Etonogestrel Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Widely Chemical Etonogestrel Product Offerings
7.6.5 Widely Chemical Recent Development
7.7 Shanghai Yuanye Bio-Technology
7.7.1 Shanghai Yuanye Bio-Technology Company Information
7.7.2 Shanghai Yuanye Bio-Technology Introduction and Business Overview
7.7.3 Shanghai Yuanye Bio-Technology Etonogestrel Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Shanghai Yuanye Bio-Technology Etonogestrel Product Offerings
7.7.5 Shanghai Yuanye Bio-Technology Recent Development
7.8 Hubei Rishengchang
7.8.1 Hubei Rishengchang Company Information
7.8.2 Hubei Rishengchang Introduction and Business Overview
7.8.3 Hubei Rishengchang Etonogestrel Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Hubei Rishengchang Etonogestrel Product Offerings
7.8.5 Hubei Rishengchang Recent Development
7.9 Wuhan NewGreat Chemical
7.9.1 Wuhan NewGreat Chemical Company Information
7.9.2 Wuhan NewGreat Chemical Introduction and Business Overview
7.9.3 Wuhan NewGreat Chemical Etonogestrel Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Wuhan NewGreat Chemical Etonogestrel Product Offerings
7.9.5 Wuhan NewGreat Chemical Recent Development
8 Industry Chain Analysis
8.1 Etonogestrel Industrial Chain
8.2 Etonogestrel Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Etonogestrel Sales Model
8.5.2 Sales Channel
8.5.3 Etonogestrel Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Etonogestrel market is projected to grow from US$ 964 million in 2025 to US$ 1255 million by 2032, at a CAGR of 3.9% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-11
Pages: 146
USD 4900.00
(Single User License)
The global Etonogestrel market size was US$ 964 million in 2025 and is forecast to reach a readjusted size of US$ 1255 million by 2032 with a CAGR of 3.9% during the forecast period 2026-2032.
Published Date: 2026-03-11
Pages: 76
USD 4250.00
(Single User License)
The global Etonogestrel market was valued at US$ 964 million in 2025 and is anticipated to reach US$ 1255 million by 2032, at a CAGR of 3.9% from 2026 to 2032.
Published Date: 2026-03-11
Pages: 128
USD 2900.00
(Single User License)
The global market for Etonogestrel was estimated to be worth US$ 964 million in 2025 and is projected to reach US$ 1255 million, growing at a CAGR of 3.9% from 2026 to 2032.
Published Date: 2026-03-08
Pages: 95
USD 3950.00
(Single User License)
The global Etonogestrel market size was US$ 933 million in 2024 and is forecast to a readjusted size of US$ 1212 million by 2031 with a CAGR of 3.9% during the forecast period 2025-2031.
Published Date: 2025-03-01
Pages: 79
USD 4250.00
(Single User License)
The global market for Etonogestrel was valued at US$ 933 million in the year 2024 and is projected to reach a revised size of US$ 1212 million by 2031, growing at a CAGR of 3.9% during the forecast period.
Published Date: 2025-03-01
Pages: 90
USD 2900.00
(Single User License)
Valued at US$ 964 million in 2024, the global Etonogestrel market is forecast to reach US$ 1212 million by 2030, at a CAGR of 3.9% during the forecast period.
Published Date: 2025-03-01
Pages: 132
USD 4900.00
(Single User License)
The global Etonogestrel market is projected to grow from US$ 964 million in 2025 to US$ 1255 million by 2032, at a CAGR of 3.9% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-11
Pages: 146
The global Etonogestrel market size was US$ 964 million in 2025 and is forecast to reach a readjusted size of US$ 1255 million by 2032 with a CAGR of 3.9% during the forecast period 2026-2032.
Published: 2026-03-11
Pages: 76
The global Etonogestrel market was valued at US$ 964 million in 2025 and is anticipated to reach US$ 1255 million by 2032, at a CAGR of 3.9% from 2026 to 2032.
Published: 2026-03-11
Pages: 128
The global market for Etonogestrel was estimated to be worth US$ 964 million in 2025 and is projected to reach US$ 1255 million, growing at a CAGR of 3.9% from 2026 to 2032.
Published: 2026-03-08
Pages: 95
The global Etonogestrel market size was US$ 933 million in 2024 and is forecast to a readjusted size of US$ 1212 million by 2031 with a CAGR of 3.9% during the forecast period 2025-2031.
Published: 2025-03-01
Pages: 79
The global market for Etonogestrel was valued at US$ 933 million in the year 2024 and is projected to reach a revised size of US$ 1212 million by 2031, growing at a CAGR of 3.9% during the forecast period.
Published: 2025-03-01
Pages: 90
Valued at US$ 964 million in 2024, the global Etonogestrel market is forecast to reach US$ 1212 million by 2030, at a CAGR of 3.9% during the forecast period.
Published: 2025-03-01
Pages: 132
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now